Copy number variation comparison between control and CC214-2 resistant GBM39 xenografts

ChEBI2013-12-06 更新2026-07-21 收录

胶质母细胞瘤耐药性

癌症拷贝数变异

数据链接：

https://www.ebi.ac.uk/biostudies/ArrayExpress/studies/E-GEOD-53042 数据链接链接失效反馈

官方服务：

资源简介：

Copy number variation comparison between control and CC214-2 resistant GBM39 xenografts

创建时间：

2013-12-06

Microarray Expression Profiles and bioinformatics analysis of mRNAs, lncRNAs and circRNAs in the secondary temozolomide-resistant glioblastoma

胶质母细胞瘤耐药性

RNA表达谱

Glioblastoma multiforme (GBM) is the most common and aggressive primary human brain tumor. Although comprehensive therapies combining radiotherapy and chemotherapy after surgery can prolong survival,

NIAID Data Ecosystem110

Transcriptomic analysis (RNA-seq) in bevacizumab-resistant xenograft mouse model

胶质母细胞瘤耐药性

癌细胞转录组

Background: Bevacizumab treatments in recurrent glioblastoma (GBM) patients have shown clinical benefits for prolonged disease-free survival (DFS) but have not improved overall survival (OV) because o

NIAID Data Ecosystem50

Establishment and characterization of a chemoresistant glioblastoma cell line from an Iraqi patient

胶质母细胞瘤耐药性

肿瘤细胞表征

Glioblastoma multiforme is a highly aggressive malignant primary brain tumor in humans, with poor prognosis. ANGM5 has been established from a cerebral glioblastoma multiforme in a 72-years-old Iraqi

NIAID Data Ecosystem40

Glioblastoma stem cell (GSC) clones survived 500uM Temozolomide (TMZ) treatment. Homo sapiens

胶质母细胞瘤耐药性

癌细胞基因表达

Comparison of parental GSC (GSC-parental) with treatment resistant GSC clones survived 500uM TMZ treatment (GSC-500uM TMZ) We used microarrays to identify defense profiles of GSC-500uM TMZ Overall des

NIAID Data Ecosystem80

Rational targeting of dynamic tumor subclones in relapsing human glioblastoma

胶质母细胞瘤耐药性

肿瘤亚克隆动态分析

Glioblastoma therapy relies on the alkylating drug temozolomide (TMZ) administered to irradiated patients post-neurosurgery, which increases overall survival but cannot prevent fatal disease relapse.

NIAID Data Ecosystem50

Copy number variation comparison between control and CC214-2 resistant GBM39 xenografts

资源简介：

相关数据集